Business Context and Reporting Period
Company: Biorestorative Therapies, Inc. (BRTX)
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2026
Reporting Period: Single event date (April 23, 2026)
Business Context: The Company is a Nevada corporation listed on the Nasdaq Capital Market. This filing serves as a Regulation FD disclosure to make an updated corporate presentation available to investors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a disclosure of non-financial presentation materials and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this filing. The sole material event is the release of an updated corporate presentation for use at conferences and investor meetings.
Guidance, Outlook, and Risks
- Management Commentary: The Company furnished an updated corporate presentation (Exhibit 99.1) via its website.
- Legal Status of Information: The information in the presentation is furnished, not filed, under the Exchange Act. It is not subject to Section 18 liabilities and is not incorporated by reference into other filings unless expressly stated.
- Investor Warning: The Company explicitly states that the furnishing of this report does not constitute a determination that the information is material or complete, nor should it be considered before making an investment decision.
Investor Verification Checklist
- Verify the content of the "Presentation Materials" (Exhibit 99.1) on the Company's website (www.biorestorative.com) to understand the specific updates made.
- Confirm that the presentation is not incorporated by reference into other SEC filings unless explicitly noted.
- Review subsequent filings (e.g., 10-Q or 10-K) for actual financial data, as this 8-K contains no financial metrics.